Kenneth Nilsson Selected Research

Kenneth Nilsson Research Topics

Disease

13	Neoplasms (Cancer) 02/2017 - 01/2003
10	Multiple Myeloma 02/2017 - 04/2004
5	Infections 06/2022 - 01/2011
2	Anaplasmosis 01/2021 - 09/2018
2	Coinfection 01/2021 - 01/2021
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2013 - 01/2004
2	Acute Promyelocytic Leukemia 11/2003 - 03/2002
1	Rickettsia Infections 01/2021
1	Facial Paralysis (Facial Palsy) 01/2021
1	Tularemia 01/2021
1	Relapsing Fever 01/2021
1	Tick-Borne Diseases (Tick-Borne Disease) 01/2021
1	Paralysis (Palsy) 01/2021
1	Bartonella Infections (Bartonellosis) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Babesiosis (Piroplasmosis) 01/2021
1	Osteoporosis 05/2019
1	Carcinogenesis 02/2017
1	Spotted Fever Group Rickettsiosis (Rickettsialpox) 09/2015
1	Lymphoma (Lymphomas) 09/2011
1	Lymphoid Leukemia 09/2011
1	Leukocytosis (Pleocytosis) 01/2011
1	Headache (Headaches) 01/2011
1	Communicable Diseases (Infectious Diseases) 01/2008
1	Tick Bites 01/2008
1	Bone Diseases (Bone Disease) 10/2007
1	Respiratory Insufficiency (Respiratory Failure) 10/2007
1	Systemic Scleroderma (Systemic Sclerosis) 10/2007
1	Idiopathic Pulmonary Fibrosis 10/2007
1	Inflammation (Inflammations) 01/2007
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2004
1	Sarcoidosis (Schaumann Disease) 04/2002
1	Granuloma 04/2002
1	Hematologic Neoplasms (Hematological Malignancy) 03/2002

Drug/Important Bio-Agent (IBA)

7	AntibodiesIBA 01/2021 - 04/2002
3	CytokinesIBA 06/2022 - 01/2007
2	Anti-Bacterial Agents (Antibiotics)IBA 10/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2016
2	Immunoglobulin M (IgM)IBA 01/2021 - 01/2011
2	AntigensIBA 09/2015 - 08/2013
2	Proteins (Proteins, Gene)FDA Link 01/2014 - 09/2011
2	Pharmaceutical PreparationsIBA 10/2007 - 03/2002
2	ParaproteinsIBA 10/2007 - 01/2006
2	Insulin-Like PeptidesIBA 10/2007 - 01/2006
2	picropodophyllinIBA 10/2007 - 01/2006
2	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 01/2004 - 01/2004
2	dicyandiamido (cyanoguanidine)IBA 01/2004 - 01/2004
1	Fibrinogen (Factor I)FDA Link 01/2021
1	Rheumatoid FactorIBA 01/2021
1	tert-butylserineIBA 01/2021
1	Bacterial DNAIBA 09/2018
1	MicroRNAs (MicroRNA)IBA 02/2017
1	Enhancer of Zeste Homolog 2 ProteinIBA 02/2017
1	Polycomb Repressive Complex 2IBA 02/2017
1	Histones (Histone)IBA 02/2016
1	Lysine (L-Lysine)FDA Link 02/2016
1	Toll-Like Receptors (Toll-Like Receptor)IBA 08/2013
1	Pattern Recognition ReceptorsIBA 08/2013
1	Scavenger Receptors (Scavenger Receptor)IBA 08/2013
1	Interleukin-6 (Interleukin 6)IBA 07/2012
1	DNA (Deoxyribonucleic Acid)IBA 01/2011
1	PanobinostatIBA 07/2010
1	Interferon Regulatory FactorsIBA 12/2008
1	Oxygen (Dioxygen)IBA 10/2007
1	MetalsIBA 10/2007
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2007
1	Small Interfering RNA (siRNA)IBA 01/2007
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2007
1	Somatomedin Receptors (Somatomedin Receptor)IBA 01/2007
1	InterferonsIBA 01/2007
1	Neutralizing AntibodiesIBA 01/2007
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2006
1	Insulin (Novolin)FDA Link 01/2006
1	IGF Type 1 Receptor (IGF 1 Receptor)IBA 01/2006
1	Sirolimus (Rapamycin)FDA Link 04/2004
1	Dexamethasone (Maxidex)FDA LinkGeneric 04/2004
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2004
1	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 11/2003
1	Thromboplastin (Tissue Factor)IBA 11/2003
1	ChemokinesIBA 11/2003
1	RetinoidsIBA 11/2003
1	Phosphotransferases (Kinase)IBA 01/2003
1	ParaffinIBA 04/2002
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2002

Therapy/Procedure

2	Therapeutics 02/2017 - 01/2006
1	Dental Care 05/2019